Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study

AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age

(2010) François Roman et al.   CLINICAL INFECTIOUS DISEASES

Are Anti-Infectious Vaccinations Safe and Effective in Patients with Autoimmunity?

(2010) Simonetta Salemi et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

(2010) Elizabeth Miller et al.   LANCET

Vaccinations in patients with immune-mediated inflammatory diseases

(2010) J.-F. Rahier et al.   RHEUMATOLOGY

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFα blockers: Safety and immunogenicity

(2009) S. Salemi et al.   CLINICAL IMMUNOLOGY

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials

(2009) Roman Prymula et al.   LANCET

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine

(2009) Tristan W. Clark et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study

(2009) A. Holvast et al.   RHEUMATOLOGY

The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

(2009) Ori Elkayam et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults

(2009) Tino F. Schwarz et al.   VACCINE

Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination

(2008) A Holvast et al.   ANNALS OF THE RHEUMATIC DISEASES

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

(2008) G Wells et al.   ANNALS OF THE RHEUMATIC DISEASES